Agitation
92
9
10
55
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
21 trials with published results (23%)
Research Maturity
55 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.5%
6 terminated out of 92 trials
90.2%
+3.6% vs benchmark
38%
35 trials in Phase 3/4
38%
21 of 55 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 55 completed trials
Clinical Trials (92)
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Neurosteer Bedside Monitoring System
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial
Life's End Benefits of cannaBidiol and tetrahYdrocannabinol
Family Videos and Virtual Reality in Intensive Care Patients
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
Study of BXCL501 In Agitation Associated With Delirium in ICU Patients
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
Impact of Harp Therapy on Behavioral Disorders in Nursing Home Residents With Neurodegenerative Disease (ARPE)
Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years
Acupressure for Agitation, Pain, and Sleep in Mechanically Ventilated ICU Patients
Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial)
PARO-agitation-study